Indication
Musculoskeletal Disorders
8 clinical trials
10 products
Product
PeresolimabClinical trial
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants With Moderately-to-Severely Active Rheumatoid ArthritisStatus: Active (not recruiting), Estimated PCD: 2023-11-20
Product
PlaceboClinical trial
Bone Marrow Aspirate ConCentrate for the Treatment of knEe Osteoarthritis: A Phase III, muLti-centER, Pan-cAnadian, prospecTivE TrialStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Product
EDG-5506Product
Radiolabeled EDG-5506Clinical trial
A Phase 1, Open-label Study in Healthy Male Subjects of the Absorption, Metabolism, Excretion, and Pharmacokinetics of EDG-5506 and an Absolute Bioavailability Study Using Radiolabeled EDG-5506Status: Completed, Estimated PCD: 2023-04-06
Clinical trial
A Phase 2 Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) PatientsStatus: Active (not recruiting), Estimated PCD: 2025-06-01
Product
AOC 1001Product
ACE-083Clinical trial
A Phase 1, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Local Muscle Injections of ACE-083 in Healthy Postmenopausal WomenStatus: Completed, Estimated PCD: 2016-03-01
Product
LEVI-04Clinical trial
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the KneeStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Clinical trial
Percutaneous Needle Fasciotomy (PNF) +/- Corticosteroid Injection for Dupuytren's Contracture (DC) Affecting Metacarpophalangeal Joints (MCP) . A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-12-01
Product
CorticosteroidClinical trial
COMPIS- Congenital Myopathy Intervention Study. An Open-label, Cross Over, Randomised, Controlled Study Using Oral SalbutamolStatus: , Estimated PCD: 2025-12-31
Product
Salbutamol